| Not Yet Recruiting | A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque Psoriasis Severe Plaque Psoriasis in Chinese Children | Phase 4 | 2026-05-01 |
| Not Yet Recruiting | A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-A Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia | Phase 2 | 2026-04-01 |
| Recruiting | To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects Myelofibrosis | Phase 1 | 2026-04-01 |
| Recruiting | Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibroma | Phase 3 | 2026-03-31 |
| Recruiting | A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis Generalized Pustular Psoriasis | Phase 2 | 2026-03-19 |
| Not Yet Recruiting | Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors Advanced Malignant Cancer | Phase 1 | 2026-03-01 |
| Not Yet Recruiting | Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Chronic Obstructive Pulmonary Disease | Phase 3 | 2026-03-01 |
| Recruiting | Clinical Trial Evaluating TQB6411 Injection in Subjects With Esophageal Cancer Esophageal Cancer | Phase 1 / Phase 2 | 2026-02-12 |
| Recruiting | A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of T Advanced Cancer | Phase 1 | 2026-01-22 |
| Not Yet Recruiting | A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection Advanced Lung Cancer | Phase 1 / Phase 2 | 2026-01-01 |
| Not Yet Recruiting | To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Advanced Malignant Tumors | Phase 1 | 2026-01-01 |
| Active Not Recruiting | A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder Pulmonary Disease, Chronic Obstructive | Phase 2 | 2025-12-22 |
| Recruiting | A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult Subjects Hyperglycemia | Phase 1 | 2025-12-18 |
| Not Yet Recruiting | A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 T Advanced Cancer | Phase 1 | 2025-12-01 |
| Not Yet Recruiting | Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obs Chronic Obstructive Pulmonary Disease | Phase 3 | 2025-09-01 |
| Not Yet Recruiting | Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets Metastatic Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | 2025-09-01 |
| Not Yet Recruiting | A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Primary Immune Thrombocytopenia | Phase 2 | 2025-08-01 |
| Withdrawn | A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infecte Chronic Hepatitis B | Phase 2 | 2025-07-09 |
| Recruiting | A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Advanced Malignant Cancer | Phase 1 | 2025-05-26 |
| Terminated | Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Breast Cancer | Phase 1 / Phase 2 | 2025-05-16 |
| Recruiting | A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia Primary Immune Thrombocytopenia | Phase 3 | 2025-04-30 |
| Recruiting | Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma | Phase 1 / Phase 2 | 2025-04-23 |
| Recruiting | A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Th Thyroid Cancer | Phase 3 | 2025-04-18 |
| Recruiting | Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemothera Advanced Pancreatic Cancer | Phase 1 / Phase 2 | 2025-04-11 |
| Recruiting | Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carb Extensive Stage Small Cell Lung Cancer | Phase 2 | 2025-04-07 |
| Not Yet Recruiting | A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects Obesity | Phase 3 | 2025-03-01 |
| Not Yet Recruiting | Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus | Phase 2 | 2025-03-01 |
| Active Not Recruiting | Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer Breast Cancer | Phase 2 | 2025-02-20 |
| Completed | A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease | Phase 1 | 2025-02-11 |
| Recruiting | Clinical Trial of TQB3002 in Patients With Advanced Cancers Advanced Cancer | Phase 1 | 2024-12-09 |
| Active Not Recruiting | Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection Chronic Hepatitis B | Phase 2 | 2024-12-04 |
| Recruiting | A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | 2024-12-03 |
| Recruiting | Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Stud Graft-versus-host Disease | Phase 3 | 2024-11-20 |
| Completed | To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency Resistant to Gram-positive, Gram-negative and Anaerobic Bacteria | Phase 1 | 2024-11-20 |
| Completed | Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs HBV Infection With LLV | Phase 2 | 2024-11-14 |
| Recruiting | A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for t B-cell Lymphoma | Phase 2 | 2024-11-06 |
| Not Yet Recruiting | Drug-Drug Interaction (DDI) Study for TQB3616 Healthy | Phase 1 | 2024-11-01 |
| Completed | To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Renal Impairment Subjects Myelofibrosis | Phase 1 | 2024-10-12 |
| Completed | A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease, Chronic Obstructive | Phase 2 | 2024-09-14 |
| Not Yet Recruiting | A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients Small Cell Lung Cancer Limited Stage | Phase 3 | 2024-09-01 |
| Not Yet Recruiting | A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Investigator-Selected Che Breast Cancer | Phase 3 | 2024-08-01 |
| Completed | To Evaluate the Pharmacokinetics and Safety of TQD3524 for Injection in Renal Impairment Subjects Multi-resistant Gram-negative Bacteria Cause Infection | Phase 1 | 2024-07-24 |
| Recruiting | Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock Vasodilatory Shock | Phase 3 | 2024-07-23 |
| Recruiting | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subj Systemic Lupus Erythematosus | Phase 1 | 2024-07-19 |
| Recruiting | Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Chronic Rhinosinusitis | Phase 2 | 2024-07-16 |
| Not Yet Recruiting | Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer Endometrial Cancer | Phase 3 | 2024-07-01 |
| Not Yet Recruiting | TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors Soft Tissue Sarcoma, Melanoma | Phase 2 | 2024-07-01 |
| Recruiting | A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors Advanced Cancers | Phase 1 | 2024-06-27 |
| Active Not Recruiting | A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Und Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | 2024-06-10 |
| Not Yet Recruiting | A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B Hepatitis B, Chronic | Phase 1 / Phase 2 | 2024-06-01 |
| Not Yet Recruiting | A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer Advanced Malignant Cancer | Phase 1 | 2024-06-01 |
| Terminated | Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Advanced Hepatocellular Carcinoma | Phase 1 | 2024-05-30 |
| Terminated | TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors. Advanced Malignant Neoplasm | Phase 1 | 2024-05-24 |
| Completed | A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects Chronic Obstructive Pulmonary Disease | Phase 1 | 2024-05-22 |
| Terminated | A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF) Myelofibrosis | Phase 1 / Phase 2 | 2024-05-13 |
| Recruiting | A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease Chronic Graft Versus Host Disease | Phase 2 | 2024-05-07 |
| Not Yet Recruiting | The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic T-lymphoblastic Leukemia, T-lymphoblastic Lymphoma | Phase 3 | 2024-05-01 |
| Completed | A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer Advanced Malignant Neoplasm | Phase 1 | 2024-04-25 |
| Recruiting | A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies Myeloid Malignancy | Phase 1 / Phase 2 | 2024-04-17 |
| Recruiting | D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-sm Non Small Cell Lung Cancer | Phase 3 | 2024-03-28 |
| Recruiting | A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nu Chronic Hepatitis B | Phase 2 | 2024-03-20 |
| Completed | A Clinical Trial of Mass Balance of [14C] TQ05105 in Healthy Chinese Subjects Mass Balance of [14C] TQ05105 in Healthy Chinese Subjects | Phase 1 | 2024-03-18 |
| Unknown | A Trial to Assess the Bioequivalence of Generic Tiotropium Bromide Inhalation Powder and Reference Product in Chronic Obstructive Pulmonary Disease | Phase 1 | 2024-02-28 |
| Active Not Recruiting | A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2 Breast Cancer | Phase 2 | 2024-02-05 |
| Unknown | A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotini Colorectal Cancer | Phase 1 | 2024-01-13 |
| Not Yet Recruiting | A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy Hematologic Malignancy | Phase 1 | 2024-01-01 |
| Unknown | Mass Balance Study of TQB3616 Breast Cancer | Phase 1 | 2024-01-01 |
| Completed | A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects Hepatitis B | Phase 1 | 2023-12-26 |
| Recruiting | A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF) Myelofibrosis | Phase 1 / Phase 2 | 2023-12-12 |
| Completed | A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps Chronic Sinusitis, Nasal Polyps | Phase 2 | 2023-12-08 |
| Active Not Recruiting | A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatmen Chronic Hepatitis b | Phase 1 / Phase 2 | 2023-12-07 |
| Unknown | A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets Advanced Malignant Neoplasm | Phase 1 | 2023-12-01 |
| Withdrawn | A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer Advanced Malignant Neoplasm | Phase 1 | 2023-12-01 |
| Unknown | A Clinical Trial of TQA3038 Injection in Healthy Adult Subjects Chronic Hepatitis b | Phase 1 | 2023-11-30 |
| Unknown | A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects Biliary Carcinoma | Phase 1 | 2023-11-01 |
| Completed | A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects Pharmacokinetic | Phase 1 | 2023-10-31 |
| Recruiting | A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chroni Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 / Phase 2 | 2023-10-11 |
| Completed | A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets Myelofibrosis | Phase 1 | 2023-09-21 |
| Active Not Recruiting | A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma. Biliary Carcinoma | Phase 3 | 2023-09-21 |
| Unknown | Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | 2023-09-01 |
| Terminated | A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2023-08-30 |
| Completed | A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Chronic Obstructive Pulmonary Disease | Phase 2 | 2023-08-23 |
| Completed | A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor Advanced Malignant Neoplasm | Phase 1 | 2023-08-16 |
| Terminated | A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules Advanced Hepatocellular Carcinoma | Phase 1 | 2023-08-15 |
| Withdrawn | A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Cervical Cancer | Phase 2 | 2023-08-01 |
| Recruiting | Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refra Thyroid Neoplasms | — | 2023-08-01 |
| Unknown | A Study of TQB3454 Tablets in Patients With Blood Tumors Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2023-07-10 |
| Unknown | A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimetha Mental Health Issue | Phase 3 | 2023-07-06 |
| Unknown | A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2023-06-19 |
| Recruiting | Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma Medullary Thyroid Cancer | Phase 4 | 2023-06-19 |
| Unknown | Study of Polyglycan Superparamagnetic Ferric Oxide Injection on Cardiovascular Magnetic Resonance Imaging Magnetic Resonance Imaging, Chronic Kidney Diseases | Phase 1 | 2023-06-17 |
| Recruiting | A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Tre Non Small Cell Lung Cancer | Phase 2 | 2023-06-14 |
| Recruiting | Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Non-small Cell Lung Cancer | Phase 3 | 2023-06-08 |
| Unknown | TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers Advanced Cancer | Phase 1 | 2023-06-06 |
| Unknown | To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2023-06-01 |
| Terminated | Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2023-05-26 |
| Unknown | A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab In Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2023-05-23 |
| Recruiting | Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcin Hepatocellular Carcinoma | Phase 3 | 2023-05-10 |
| Recruiting | A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Brea Metastatic Breast Cancer, Recurrent Breast Cancer, Advanced Malignancies | Phase 1 / Phase 2 | 2023-04-13 |
| Active Not Recruiting | Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined W Breast Cancer | Phase 3 | 2023-03-30 |
| Completed | Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State Thrombocytopenia | N/A | 2023-03-20 |
| Unknown | A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects Multiple Myeloma | Phase 1 | 2023-03-17 |
| Unknown | A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer Advanced Breast Cancer | Phase 1 / Phase 2 | 2023-03-02 |
| Completed | Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer Differentiated Thyroid Cancer | Phase 1 / Phase 2 | 2023-02-24 |
| Completed | Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer Advanced Lung Cancer, Ovarian Cancer | Phase 2 | 2023-02-15 |
| Unknown | TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride C Advanced Squamous Non-Small Cell Lung Carcinoma | Phase 3 | 2023-02-01 |
| Unknown | Material Balance Study of TQ-B3525 Chronic Kidney Diseases, Magnetic Resonance Imaging | Phase 1 | 2023-01-01 |
| Unknown | A Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test Asthma | N/A | 2022-12-01 |
| Unknown | Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects Hematologic Malignancy | Phase 1 | 2022-11-01 |
| Completed | TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Na Nasopharyngeal Carcinoma | Phase 2 | 2022-10-27 |
| Unknown | Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction Patients Liver Dysfunction | Phase 1 | 2022-10-01 |
| Completed | Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma. Severe Asthma | Phase 2 | 2022-09-23 |
| Terminated | To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic Rhinitis Allergic Rhinitis | Phase 1 | 2022-09-14 |
| Unknown | A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors Solid Tumor | Phase 1 | 2022-09-02 |
| Terminated | Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Adv Advanced Endometrial Cancer, Sarcoma of Uterus | Phase 2 | 2022-08-26 |
| Terminated | To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistan Metastatic Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | 2022-08-25 |
| Unknown | Efficacy and Safety of TQB2618 Injection Combined With Toripalimab Injection in Patients With Advanced Melanom Melanoma | Phase 1 | 2022-08-09 |
| Terminated | TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma Dedifferentiated Liposarcoma | Phase 2 | 2022-08-08 |
| Terminated | TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients Myelofibrosis | Phase 1 | 2022-08-01 |
| Unknown | Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers Advanced Cancers | Phase 1 | 2022-07-29 |
| Active Not Recruiting | To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination W HR-positive, HER2-negative Breast Neoplasms | Phase 3 | 2022-07-01 |
| Completed | A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD) Glucocorticoid-Refractory aGVHD | Phase 1 / Phase 2 | 2022-06-10 |
| Unknown | To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients Relapsed/Refractory Lymphoma | Phase 1 / Phase 2 | 2022-06-09 |
| Unknown | Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors Advanced Malignant Tumor | Phase 1 | 2022-06-01 |
| Unknown | Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers Granulomatosis With Polyangiitis, Hemophagocytic Syndrome | EARLY_Phase 1 | 2022-06-01 |
| Completed | A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects Rheumatoid Arthritis | Phase 1 | 2022-05-29 |
| Terminated | A Phase II Clinical Trial of TQC3721 Suspension for Inhalation Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | 2022-05-20 |
| Unknown | Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refract Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | 2022-04-29 |
| Unknown | Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2022-04-28 |
| Unknown | Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia Hemophilia A, Hemophilia B | Phase 3 | 2022-04-28 |
| Unknown | To Evaluate the Pharmacokinetic Effects of TQD3606 for Injection in Healthy Adult Subjects Infections | Phase 1 | 2022-04-01 |
| Completed | TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in HR-positive,HER2-negative in Advanced Breast Cancer | Phase 3 | 2022-03-18 |
| Unknown | TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung C Nonsmall-cell Lung Cancer | Phase 1 / Phase 2 | 2022-03-11 |
| Unknown | A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubici Soft Tissue Sarcoma | Phase 3 | 2022-03-01 |
| Unknown | A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors Advanced Malignant Tumor | Phase 1 | 2022-02-18 |
| Unknown | A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Che Advanced Non-squamous Non-small Cell Lung Cancer | Phase 3 | 2022-01-25 |
| Terminated | Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors Advanced Cancer, Advanced Soft-tissue Sarcoma | Phase 1 / Phase 2 | 2022-01-14 |
| Unknown | A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advance Advanced Malignant Tumors | Phase 1 | 2022-01-05 |
| Unknown | To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyng Recurrent / Metastatic Nasopharyngeal Cancer | Phase 1 / Phase 2 | 2022-01-01 |
| Unknown | A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Advanced Cervical Cancer | Phase 1 | 2021-12-09 |
| Unknown | A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment Endometrial Carcinoma | Phase 2 | 2021-12-01 |
| Unknown | A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advance Solid Tumor | Phase 1 | 2021-11-30 |
| Active Not Recruiting | A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis Moderate and High Risk Myelofibrosis | Phase 2 | 2021-11-11 |
| Completed | Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Diabetes, Magnetic Resonance Imaging | Phase 1 / Phase 2 | 2021-11-06 |
| Unknown | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofi Type I Neurofibromatosis | Phase 1 | 2021-11-01 |
| Unknown | A Clinical Trial of TQC3721 Suspension for Inhalation Chronic Obstructive Pulmonary Disease | Phase 1 | 2021-10-18 |
| Unknown | A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (Cape Unresectable Metastatic Colorectal Cancer | Phase 2 | 2021-10-08 |
| Completed | Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets Chronic Hepatitis B | Phase 1 | 2021-10-01 |
| Unknown | A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Week Recurrent Platinum-resistant Ovarian Cancer | Phase 3 | 2021-09-28 |
| Unknown | A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor Advanced Solid Tumor | Phase 1 | 2021-09-23 |
| Terminated | A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurof Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors | Phase 1 / Phase 2 | 2021-09-07 |
| Unknown | A Study of TQB3820 in Patients With Hematological Malignancies Hematological Malignancies | Phase 1 | 2021-08-31 |
| Unknown | A Clinical Study of TQB3824 in Subjects With Advanced Cancer Advanced Cancer | Phase 1 | 2021-08-31 |
| Terminated | A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy S Advanced Lung Carcinoma | Phase 2 | 2021-08-18 |
| Unknown | A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Trea Non Small Cell Lung Cancer | Phase 3 | 2021-08-06 |
| Unknown | Phase 1 Trial of the TQB2928 Injection in Patients With Advanced Cancers Advanced Solid Tumors and Hematological Malignancies | Phase 1 | 2021-08-01 |
| Unknown | A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2021-07-27 |
| Unknown | Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Ci Primary Biliary Cirrhosis | Phase 3 | 2021-07-22 |
| Completed | To Evaluate the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult Subjects Myelofibrosis | Phase 1 | 2021-07-19 |
| Completed | Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult Subjects Recurrent/Metastatic Breast Cancer | Phase 1 | 2021-07-06 |
| Active Not Recruiting | A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease Chronic Graft Versus Host Disease | Phase 1 / Phase 2 | 2021-06-25 |
| Unknown | Phase I Clinical Trial of TQC2731 Injection Asthma Severe Persistent Controlled | Phase 1 | 2021-06-25 |
| Completed | A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Re Nasopharyngeal Carcinoma | Phase 2 | 2021-06-15 |
| Terminated | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets Metastatic Castration-resistant Prostate Cancer | Phase 1 | 2021-06-09 |
| Terminated | A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lympho Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Phase 1 / Phase 2 | 2021-06-05 |
| Active Not Recruiting | A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With Metastatic Colorectal Cancer | Phase 3 | 2021-05-27 |
| Completed | A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects Pharmacokinetic Study | Phase 1 | 2021-05-20 |
| Completed | Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle Magnetic Resonance Imaging | EARLY_Phase 1 | 2021-04-28 |
| Unknown | A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Advanced Endometrial Cancer, Cervical Cancer and Ovarian Cancer | Phase 2 | 2021-04-23 |
| Unknown | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignan Terminal Malignant Tumors | Phase 1 | 2021-04-23 |
| Unknown | A Study of Anlotinib Hydrochloride Capsules in Subjects With Diffuse Large B-Cell Lymphoma Diffuse Large B-cell Lymphoma | Phase 2 | 2021-04-01 |
| Unknown | Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules Advanced Solid Tumors | Phase 1 | 2021-02-23 |
| Completed | A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer HR-positive, HER2-negative Advanced Breast Cancer | Phase 2 | 2021-02-04 |
| Unknown | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subject Advanced Biliary Cancer | Phase 3 | 2021-02-04 |
| Unknown | A Study of TQ-B3525 in Subjects With Relapse/Refractory Diffuse Large B-cell Lymphoma （DLBCL） Diffuse Large B-cell Lymphoma | Phase 2 | 2021-01-20 |
| Unknown | A Study of TQ-B3525 in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma（PTCL） Peripheral T-cell Lymphoma | Phase 2 | 2020-12-01 |
| Unknown | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2618 Injection in Subjects With Advanced Solid Tu Advanced Solid Tumors | Phase 1 | 2020-12-01 |
| Unknown | Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia. Hemophilia A With Inhibitor, Hemophilia B With Inhibitor | Phase 1 | 2020-12-01 |
| Unknown | A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer Recurrent or Metastatic Cervical Cancer | Phase 2 | 2020-11-30 |
| Unknown | A Phase I Study of TQB728 Tablets on Tolerance and Pharmacokinetics Advanced Solid Tumor or Hematologic Tumor | Phase 1 | 2020-10-26 |
| Unknown | Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and HER2-positive Breast Cancer | Phase 3 | 2020-10-20 |
| Unknown | A Study of TQB3473 Tablets in Subjects With Relapsed or Refractory Hematological Malignancies Relapsed/Refractory Hematological Malignancies | Phase 1 | 2020-10-12 |
| Completed | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometri Advanced Endometrial Cancer | Phase 2 | 2020-09-29 |
| Terminated | A Phase I Study of TQ-B3456 on Tolerance and Pharmacokinetics Non-small Cell Lung Cancer | Phase 1 | 2020-09-24 |
| Unknown | A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metast Bone Metastatic Non-small Cell Lung Cancer | Phase 2 | 2020-09-24 |
| Active Not Recruiting | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With A Advanced Renal Cancer | Phase 3 | 2020-08-25 |
| Unknown | A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 Tablets Advanced Solid Tumor or Hematologic Tumor | Phase 1 | 2020-08-24 |
| Unknown | A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer Non Small Cell Lung Cancer | Phase 2 | 2020-08-11 |
| Active Not Recruiting | A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib Advanced Hepatocellular Carcinoma (HCC) | Phase 3 | 2020-08-11 |
| Unknown | A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor Advanced Malignant Tumor | Phase 2 | 2020-08-05 |
| Unknown | A Study of TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL) Relapsed / Refractory Mantle Cell Lymphoma (MCL) | Phase 2 | 2020-07-20 |
| Unknown | A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Can Advanced Colorectal Cancer | Phase 1 / Phase 2 | 2020-07-20 |
| Unknown | A Study of TQ05105 Tablets in Subjects With Hemophagocytic Lymphohistiocytosis（HLH） Hemophagocytic Lymphohistiocytosis | Phase 1 | 2020-07-17 |
| Unknown | A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2020-07-06 |
| Terminated | A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets Non Small Cell Lung Cancer | Phase 1 / Phase 2 | 2020-07-06 |
| Unknown | A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative an HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer | Phase 1 / Phase 2 | 2020-07-01 |
| Unknown | A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3558 Tablets Advanced Solid Tumors | Phase 1 | 2020-06-25 |
| Unknown | A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neur Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors | Phase 2 | 2020-06-03 |
| Unknown | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Al Triple Negative Breast Cancer | Phase 3 | 2020-06-01 |
| Unknown | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3602 Capsule Multiple Myeloma | Phase 1 | 2020-05-28 |
| Unknown | A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC) Stage III Non-small-cell Lung Cancer | Phase 3 | 2020-05-27 |
| Unknown | A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL) Relapsed / Refractory Follicular Lymphoma | Phase 2 | 2020-05-20 |
| Unknown | A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma | Phase 3 | 2020-05-20 |
| Unknown | A Study of Anlotinib and AK105 Injection in Subjects With Advanced Head, Neck and Chest Cancer Advanced Head, Neck and Chest Cancer | Phase 2 | 2020-05-09 |
| Unknown | Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2020-04-29 |
| Unknown | A Study of TQB3455 Tablets in Subjects With Advanced Malignancies Advanced Malignancies | Phase 1 | 2020-04-10 |
| Unknown | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets Advanced Malignant Solid Tumor | Phase 1 | 2020-04-01 |
| Unknown | A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC) Primary Biliary Cirrhosis | Phase 2 | 2020-03-20 |
| Unknown | A Study of TQB2450 Injection Combined With Stereotactic Body Radiation Therapy (SBRT) in Subjects With Advance Advanced Oligometastatic Non-small Cell Lung Cancer | Phase 2 | 2020-03-01 |
| Unknown | A Study of Anlotinib Combined With AK105 Injection in Subjects With Microsatellite Instability-High (MSI-H) or MSI-H or dMMR Advanced Solid Tumors | Phase 2 | 2020-03-01 |
| Unknown | A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer Gynecological Cancer | Phase 1 / Phase 2 | 2020-02-27 |
| Completed | Bioequivalence Test of Eltrombopag Olamine Tablets in Humans Under Fasting State Thrombocytopenia | N/A | 2020-01-02 |
| Unknown | A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carbopla Extensive Small Cell Lung Cancer | Phase 3 | 2020-01-01 |
| Unknown | Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 2 | 2020-01-01 |
| Unknown | A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL) Relapsed/Refractory Anaplastic Large Cell Lymphoma (ALCL) | Phase 2 | 2019-11-29 |
| Unknown | A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B Chronic Hepatitis B | Phase 2 | 2019-11-18 |
| Unknown | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors Advanced Malignant Tumors | Phase 1 | 2019-11-15 |
| Completed | Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy M Gastric Cancer, Non-small Cell Lung Cancer, Colo-rectal Cancer | Phase 1 | 2019-11-04 |
| Unknown | Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer Small Cell Lung Cancer | Phase 3 | 2019-10-31 |
| Unknown | Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell L Squamous Non-small Cell Lung Cancer | Phase 3 | 2019-10-31 |
| Recruiting | A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | Phase 1 | 2019-10-22 |
| Unknown | Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (A ALK-positive NSCLC | Phase 3 | 2019-08-13 |
| Unknown | Study of TQ-B3139 in Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC ALK-positive NSCLC | Phase 2 | 2019-08-13 |
| Unknown | A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combi Advanced Non-squamous Cell Non-small Cell Lung Cancer | Phase 3 | 2019-08-08 |
| Terminated | Study of TQB2450 Injection in Subjects With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma Relapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL) | Phase 2 | 2019-08-06 |
| Unknown | Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC) ROS1-positive Non-Small Cell Lung Cancer (NSCLC) | Phase 2 | 2019-07-24 |
| Unknown | Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma Advanced Cholangiocarcinoma | Phase 1 / Phase 2 | 2019-06-24 |
| Unknown | Study of TQB2450 Combined With Anlotinib in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2019-06-20 |
| Unknown | Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC） Non-small Cell Lung Cancer | Phase 1 | 2019-06-11 |
| Unknown | Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Acral Malignant Melanoma Advanced Acral Malignant Melanoma | Phase 1 / Phase 2 | 2019-06-11 |
| Unknown | Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN） Squamous Cell Carcinoma of the Head and Neck | Phase 3 | 2019-06-11 |
| Unknown | Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer Lung Cancer | Phase 1 / Phase 2 | 2019-06-03 |
| Completed | Bioequivalence Study of Trifluridine and Tipiracil Tablets in Colorectal Cancer Patients Colorectal Cancer | Phase 1 | 2019-05-21 |
| Completed | Human Bioequivalence Test of Liraglutide Injection Type 2 Diabetes | Phase 1 | 2019-05-21 |
| Completed | A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics Advanced Breast Cancer | Phase 1 | 2019-05-20 |
| Unknown | Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A. Hemophilia A | Phase 3 | 2019-05-15 |
| Unknown | A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC Triple Negative Breast Cancer (TNBC) | Phase 1 | 2019-05-09 |
| Unknown | Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A. Hemophilia A | Phase 1 | 2019-05-08 |
| Unknown | A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2019-04-23 |
| Unknown | A Phase II Study to Evaluate the Safety and Efficacy of TQB2450 Injection in Relapsed or Refractory Classical Safety and Effectiveness | Phase 2 | 2019-03-25 |
| Unknown | Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL) Diffuse Large B-cell Lymphoma | Phase 3 | 2019-01-10 |
| Completed | A Bioequivalence Study of Sunitinib Malate Capsules. Gastrointestinal Stromal Tumors, Renal Cell Carcinoma, Pancreatic Neuroendocrine Tumor | Phase 1 | 2018-12-04 |
| Completed | Bioequivalence Study of Entecavir Tablets and Baraclude® Under Fasting Condition in Chinese Healthy Volunteers Chronic Hepatitis b | N/A | 2018-12-04 |
| Unknown | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3474 Injection Advanced Solid Tumor | Phase 1 | 2018-11-27 |
| Unknown | A Study of TQ05105 Tablets in Subjects With Myeloproliferative Neoplasms Myeloproliferative Neoplasms | Phase 1 | 2018-11-20 |
| Unknown | A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2 HER2-positive Metastatic Breast Cancer | Phase 3 | 2018-11-11 |
| Unknown | Pharmacokinetic and Tolerance Study of TQ-A3326 in Healthy Participants. Pharmacokinetic | Phase 1 | 2018-11-11 |
| Completed | A Bioequivalence Study of Dasatinib Tablet Leukemia, Myelogenous, Chronic | Phase 1 | 2018-09-09 |
| Unknown | Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 3 | 2018-08-27 |
| Completed | A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Canc Pancreatic Cancer | Phase 1 / Phase 2 | 2018-08-23 |
| Unknown | A Study of TQ-B3525 on Tolerance and Pharmacokinetics Relapsed or Refractory Lymphoma or Advanced Cancer | Phase 1 | 2018-06-20 |
| Completed | Bioequivalence Study of Empagliflozin Tablet in Healthy Participants. Type 2 Diabetes | N/A | 2018-04-16 |
| Unknown | Tolerance and Pharmacokinetics of TQB2450 Tumor | Phase 1 | 2018-03-15 |
| Unknown | Study of Anlotinib in Patients With Primary Malignant Bone Tumors Neoplasm of Bone | Phase 2 | 2018-01-31 |
| Unknown | A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3 Gastroenteropancreatic Neuroendocrine Tumor G3 | Phase 2 | 2018-01-30 |
| Unknown | A New Drug Used for Advanced Cancer Cancer | Phase 1 | 2017-12-26 |
| Unknown | Tolerance and Pharmacokinetics of TQ-B3233 Tumor | Phase 1 | 2017-11-22 |
| Terminated | A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics Advanced Cancer | Phase 1 | 2017-09-13 |
| Unknown | A Phase I Study of TQ-B3139 on Tolerance and Pharmacokinetics Advanced Cancer | Phase 1 | 2017-07-19 |
| Completed | Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Heal Metastatic Breast Cancer, Metastatic Gastric Cancer | Phase 1 | 2017-07-16 |
| Unknown | A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics Advanced Cancer | Phase 1 | 2017-07-05 |
| Unknown | A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics Advanced Cancer | Phase 1 | 2017-05-11 |
| Unknown | Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma Non-hodgkin's Lymphoma | Phase 1 / Phase 2 | 2017-05-01 |
| Completed | A Phase I Clinical Trial of Bevacizumab Injection Rectal Cancer, Lung Cancer, Ovarian Cancer | Phase 1 | 2017-04-06 |
| Unknown | Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma Asthma | Phase 3 | 2017-04-01 |
| Completed | Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202) Small Cell Lung Cancer | Phase 2 | 2017-03-27 |
| Unknown | A Study of Anlotinib in Patients With Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 2 | 2016-09-01 |
| Unknown | Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemop Hemophilia A | Phase 3 | 2016-08-01 |
| Completed | A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Pati Advanced Cancer | Phase 1 | 2016-06-01 |
| Completed | A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-C Chronic Myelogenous Leukemia - Chronic Phase | Phase 4 | 2016-05-10 |
| Unknown | A Study of AL2846 on Tolerance and Pharmacokinetics Advanced Cancer | Phase 1 | 2016-05-01 |
| Unknown | A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics Cancer | Phase 1 | 2016-04-27 |
| Terminated | A Multicenter Randomized Double-blind Clinical Study Evaluated the Safety, Pharmacokinetic and Pharmacodynamic Chronic Obstructive Pulmonary Disease | Phase 2 | 2016-03-01 |
| Completed | Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102) Esophageal Squamous Cell Carcinoma | Phase 2 | 2016-01-01 |
| Completed | Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Can Advanced Solid Tumors | Phase 1 | 2015-12-02 |
| Completed | Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031) Medullary Thyroid Carcinoma | Phase 2 / Phase 3 | 2015-07-01 |
| Unknown | Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032) Differentiated Thyroid Cancer | Phase 2 / Phase 3 | 2015-07-01 |
| Unknown | Study of Anlotinib in Patients With Gastric Cancer(ALTER0503) Gastric Cancer | Phase 2 / Phase 3 | 2015-06-01 |
| Unknown | Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203) Soft Tissue Sarcoma | Phase 2 / Phase 3 | 2015-05-12 |
| Unknown | Study of Methylnaltrexone in Opioid-Induced Constipation Patients Opioid-induced Constipation | Phase 2 / Phase 3 | 2015-04-01 |
| Unknown | A Study of Sinotecean on Tolerance and Pharmacokinetics Advanced Cancer | Phase 1 | 2015-03-01 |
| Completed | Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303） Non-small Cell Lung Cancer | Phase 2 / Phase 3 | 2015-02-26 |
| Completed | Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703) Metastatic Colorectal Cancer | Phase 2 / Phase 3 | 2014-12-01 |
| Unknown | Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B Chronic Hepatitis B | N/A | 2014-09-01 |
| Completed | Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate Cancer Metastatic Castration Resistant Prostate Cancer | Phase 3 | 2014-07-16 |
| Unknown | Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding Bleeding Gastric Ulcer, Bleeding Duodenal Ulcer | N/A | 2014-02-01 |
| Unknown | Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC） Anlotinib, RCC | Phase 2 | 2013-12-01 |
| Unknown | Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant Renal Cell Carcinoma | Phase 2 | 2013-12-01 |
| Unknown | To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes i Non-small Cell Lung Cancer | Phase 2 / Phase 3 | 2013-12-01 |
| Unknown | Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults Hospital-acquired Pneumonia | Phase 2 | 2013-10-01 |
| Unknown | A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia Community Acquired Pneumonia | Phase 3 | 2013-10-01 |
| Completed | Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302） Non-small Cell Lung Cancer | Phase 2 | 2013-08-01 |
| Completed | A Study of Anlotinib in Subjects With Advanced Malignancy Advanced Malignancy | Phase 2 | 2013-08-01 |
| Completed | A Phase II Study of Anlotinib in MTC Patients Tumor | Phase 2 | 2013-04-01 |
| Completed | A Phase II Study of Anlotinib in STS Patients Cancer | Phase 2 | 2013-04-01 |
| Unknown | A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics Solid Tumor | Phase 1 | 2013-03-01 |
| Completed | A Bioequivalence Study of Capecitabine Tablets Metastatic Breast Cancer or Metastatic Colorectal Cancer | Phase 1 | 2012-12-01 |
| Completed | Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body Chronic Myeloid Leukemia | Phase 1 | 2012-09-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection Indolent B-Cell Non-Hodgkin's Lymphomas | Phase 2 | 2012-05-01 |
| Completed | A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics Advanced Cancer | Phase 1 | 2011-05-01 |
| Completed | A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia Community Acquired Pneumonia | Phase 2 | 2011-04-01 |
| Completed | Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B Chronic Hepatitis B | Phase 4 | 2008-10-01 |
| Completed | Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Drug-Induced Liver Injury | Phase 2 | 2007-12-01 |